Skip to main content
Caplight Logo









Cape Bio Pharms

Cape Bio Pharms

Private
Cape TownHealthcare & Life Scienceshttps://capebiologix.com/

Last Round

Grant

Dec 18, 2020

Total Funding Raised

$44.78M

Company Overview

Cape Bio Pharms is a biotechnology company that produces recombinant proteins, antibodies, and enzymes using a proprietary plant-based expression platform for use in biomedical research and diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

recombinant proteinsplant-based expressionmolecular farmingcontract development and manufacturing organizationCDMObiomedical reagentsanimal-free antibodiescustom protein expressionNicotiana benthamianadiagnostic reagentsbiotech manufacturingbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cape Bio Pharms Comparables

Compare Cape Bio Pharms with similar companies based on industry and business-model similarity.

Cape Bio Pharms comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SwiftPharma
84%
Baiya Phytopharm
79%
KBio Inc.
78%

Cape Bio Pharms Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 18, 2020
VC RoundAug 14, 2020
VC RoundMay 6, 2019
GrantNov 22, 2018
SeedFeb 27, 2017

Cape Bio Pharms Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 18, 2020

    $45M grant received from European Investment Bank Group and FIND.

  • Aug 14, 2020

    Funded by Stocks & Strauss Fund Manager.

Cape Bio Pharms Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cape Bio Pharms Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cape Bio Pharms's valuation, stock price, and market status.

Firmographic Details

HeadquartersCape Town
Year Founded2018
Last FundingDec 18, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?